Search Results for "Cvs Minute Clinic Shingles Vaccine"

19:37 EDT 8th October 2015 | BioPortfolio

Matching Channels


Varicella zoster virus (VZV) is one of eight herpes viruses known to infect humans (and other vertebrates). Varicella-zoster virus is known by many names, including: chickenpox virus, varicella viru...

HPV vaccine

Rotavirus Vaccine GSK

Smallpox Vaccine MVA

Poliovirus Vaccine OPV

Matching News

A New Vaccine to Protect Against Shingles

Paul A. Offit, MD, describes new research on a vaccine for shingles that could be a great step forward. Medscape Infectious Diseases

BRIEF-GSK's Shingles vaccine shows 97 pct efficacy in phase 3 study

* Candidate vaccine for prevention of Shingles demonstrates overall efficacy of 97.2 pct which does not diminish in age groups studied

GSK Shingles Vaccine Demonstrates 97.2% Efficacy in Phase 3 Study

GlaxoSmithKline presented detailed data from a randomized phase 3 study of its investigational vaccine candidate for the prevention of shingles, HZ/su, showing vaccine efficacy was maintained across ...

GSK pushes more data for shingles vaccine, but no filing yet

Analysis of the primary endpoint showed a two-dose schedule of HZ/su reduced the risk of shingles by 97.2% (95% confidence interval [CI] 93.7-99.0) in adults aged 50 years and older compared with plac...

GSK shingles vaccine shows benefits across all age groups

LONDON (Reuters) - An experimental shingles vaccine from GlaxoSmithKline is effective across all age groups, researchers said on Tuesday, boosting the prospects of a key product in the British drugmak...

Shingles vaccine not cost effective before age 60

(Reuters Health) - The shingles vaccine might not be cost-effective for people in their fifties, a new analysis suggests.

GSK shingles vaccine performs

GlaxoSmithKline’s HZ/su vaccine candidate for the prevention of shingles has demonstrated promising benefits across all age groups in a late-stage study.  Data presented at a Copenhagen confere...

Benefits of New Shingles Vaccine May Extend to More Patients

Phase 3 study results indicate that the HZ/su vaccine potentially offers more robust protection to the elderly and the immunocompromised than the existing vaccine. Medscape Optometry

Matching PubMed Articles

Risk of Shingles in Adults with Primary Sjogren's Syndrome and Treatments: A Nationwide Population-Based Cohort Study.

Primary Sjögren's syndrome (pSS) is associated with immunological dysfunctions-a well-known risk factor of shingles. This study aimed to examine the incidence and risk of shingles in adults with pSS ...

Modular vaccine packaging increases packing efficiency.

Within a typical vaccine supply chain, vaccines are packaged into individual cylindrical vials (each containing one or more doses) that are bundled together in rectangular "inner packs" for transport ...

Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.

Tajikistan, considered highly endemic area for hepatitis B virus (HBV) in a pre-vaccine era, introduced hepatitis B vaccine in 2002 and reported ≥80% coverage with three doses of hepatitis B vaccine...

Correction: Rule out pulmonary tuberculosis: Clinical and radiographic clues for the internist.

In the article "Rule out pulmonary tuberculosis: Clinical and radiographic clues for the internist" (Curley CA. Cleve Clin J Med 2015; 82:32-38), on page 33, "Bacillus Calmette-Guérin vaccine" has be...

The immunogenicity and safety of zoster vaccine in Taiwanese adults.

The efficacy and safety of ZOSTAVAX™ in subjects 60 years of age and older was established in the Shingles Prevention Study (SPS) and in subjects 50 to 59 years of age in the ZOSTAVAX™ Efficacy an...

Search Whole site using Google


Advertisement Advertisement